Alss Secures $7M Series B Funding To Commercialize Novel Vaccine Delivery System For Poultry Industry
May 12, 2021•over 4 years ago
Amount Raised
$7 Million
Round Type
series b
Description
Applied LifeSciences & Systems (ALSS) announced today the initial close of a $7 million Series B equity financing. The financing was co-led by Merck Animal Health and Mountain Group Partners. Oval Park Capital, a Raleigh-based early-stage investment firm also has participated in the round. ALSS integrates its proprietary technologies in high-speed imaging, feature recognition, artificial intelligence, robotics and microfluidics in a system currently developed for the commercial poultry industry